LAS VEGAS, May 21, 2024--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company"), today announced a $7 million investment in MyMD Pharmaceuticals, Inc ...

PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) provides an update on its investigation of its Cell-in-a-Box technology and initial ...

As of March 7 at 9:32:25 AM EST. Market Open.

PharmaCyte Biotech has lower revenue, but higher earnings than argenx. argenx is trading at a lower price-to-earnings ratio than PharmaCyte Biotech, indicating that it is currently the more ...

At close: 7 March at 16:00:01 GMT-5 ...